Setmelanotide trial data shows promise for treatment of obesity
30 Sep 2021
Clinical trial data, presented by Rhythm Pharmaceuticals at the 59th Annual European Society for Paediatric Endocrinology Meeting, indicates that setmelanotide has efficacy in treating rare genetic causes of obesity.
